Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies	Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride)	Colorectal cancer	Gastrointestinal Cancer , Oncology	2023	View \| Download
Tazemetostat for treating relapsed or refractory follicular lymphoma after two therapies	Tazemetostat (E7438;EPZ-6438;Tazverik)	Follicular lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Telisotuzumab vedotin for previously treated c-MET overexpressing EGFR wild-type non-squamous non-small cell lung cancer	Telisotuzumab vedotin (ABBV-399;ABBV 399;ABBV399;ABT-399;Teliso-V)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tenecteplase for treating acute ischaemic stroke	Tenecteplase	Acute ischaemic stroke	Cardiovascular System	2023	View \| Download
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps	Tezepelumab (AMG 157; MEDI9929)	Nasal polyps , Rhinosinusitis	Ear Nose and Throat (ENT)	2023	View \| Download
Tiragolumab with atezolizumab and pemetrexed and carboplatin or cisplatin for previously untreated advanced non-small-cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tiragolumab with atezolizumab for oesophageal squamous cell cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Oesophageal squamous cell carcinoma	Head and Neck Cancer	2023	View \| Download
Tiragolumab with atezolizumab for treating stage III non-small cell lung cancer after platinum-based chemoradiotherapy	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tocilizumab biosimilar for treating moderate to severe active rheumatoid arthritis	Tocilizumab biosimilar (Avtozma)	Rheumatoid arthritis	Rheumatology	2023	View \| Download
Tolebrutinib for treating relapsing and progressive forms of multiple sclerosis	Tolebrutinib (PRN-2246;SAR-442168)	Multiple sclerosis (MS)	Neurology	2023	View \| Download